Table 2.

HPV genotype distribution of 1,224 participants at the baseline and their changes at follow-up

HPV type	Total	HPV positive at baseline (n=105)			HPV negative at baseline (n=1,119)
		Persistence at follow-upa)	Clearance at follow-upa)	Reinfection at follow-upa)	Incidence at follow-upa)
Alla)	105	13 (12.4)	92 (87.6)	12 (11.4)	54 (4.8)
High risk	90	10 (11.1)	80 (88.9)	9 (8.6)	47 (4.2)
HPV 16	10	2 (20.0)	8 (80.0)	0	6 (0.5)
HPV 18	5	0	5 (100)	0	3 (0.3)
HPV 31	1	0	1 (100)	0	3 (0.3)
HPV 33	3	1 (33.3)	2 (66.7)	0	0
HPV 35	5	1 (20.0)	4 (80.0)	0	0
HPV 39	10	1 (10.0)	9 (90.0)	1 (1.0)	7 (0.6)
HPV 45	4	1 (25.0)	3 (75.0)	1 (1.0)	1 (0.1)
HPV 51	11	0	11 (100)	1 (1.0)	6 (0.5)
HPV 52	15	3 (20.0)	12 (80.0)	4 (3.8)	7 (0.6)
HPV 56	12	1 (8.3)	11 (91.7)	1 (1.0)	4 (0.4)
HPV 58	6	0	6 (100)	0	6 (0.5)
HPV 59	1	0	1 (100)	0	2 (0.2)
HPV 68	7	0	7 (100)	1 (1.0)	2 (0.2)
Low risk	90	7 (7.8)	83 (92.2)	8 (7.6)	48 (4.3)
HPV 6	3	0	3 (100)	0	0
HPV 40	2	0	2 (100)	0	0
HPV 42	1	1 (100)	0	1 (1.0)	2 (0.2)
HPV 54	5	1 (20.0)	4 (80.0)	1 (1.0)	3 (0.3)
HPV 53	15	1 (6.7)	14 (94.3)	0	8 (0.7)
HPV 55	6	1 (16.7)	5 (83.3)	2 (1.9)	2 (0.2)
HPV 61	3	1 (33.3)	2 (66.7)	1 (1.0)	4 (0.4)
HPV 62	11	1 (9.1)	10 (98.9)	1 (1.0)	4 (0.4)
HPV 66	15	0	15 (100)	0	1 (0.1)
HPV 70	10	0	10 (100)	1 (1.0)	2 (0.2)
HPV 71	4	0	4 (100)	1 (1.0)	2 (0.2)
HPV 72	2	0	2 (100)	0	1 (0.1)
HPV 81	4	0	4 (100)	0	6 (0.5)
HPV 83	1	0	1 (100)	0	3 (0.3)
HPV 84	6	1 (16.7)	5 (83.3)	0	6 (0.5)
CP6108	2	0	2 (100)	0	2 (0.2)

Values are presented as number (%).

^a)Same women can be counted more than once because of multiple infections.